3 results
Approved WMOCompleted
The objective of the study is to assess the safety, tolerability and efficacy of PRO044.
Not approvedWill not start
To determine the effect of lidocaine on the main symptoms of COVID-19.
Approved WMORecruiting
To investigate how safe the new medicine pralsetinib is when it is administered to patients with non-resectable advanced solid tumor cancers including non-small cell lung cancer (NSCLC) and Thyroid cancers.